|
Mylan Can Market Generic Detrol LA in January 2014 Per Pfizer Settlement
Mylan will be able to sell a generic version of Pfizer’s long-acting overactive bladder drug Detrol LA on Jan. 1, 2014, or earlier pending certain undisclosed terms of a settlement negotiated by the two drugmakers.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives